52 Recruiting Trials

Clinical Trials
for Obesity in Massachusetts

52 clinical trials for Obesity are currently recruiting participants at study sites in Massachusetts. Study-related care is provided at no cost.

52
Recruiting trials
37
Study sites
12
Cities
24
Industry-sponsored
7
Phase 2
18
Phase 3

Obesity clinical trials in Massachusetts: what to expect

Obesity trials are among the most actively recruiting studies in the United States right now. Most test medicines from the GLP-1 family (the class that includes semaglutide and tirzepatide) or newer compounds that work on the same appetite and blood-sugar pathways, often in people who also have high blood pressure, sleep apnea, knee osteoarthritis or prediabetes. A smaller number study structured diet and exercise programs, devices, or weight-loss surgery.

In Massachusetts, recruiting obesity studies are concentrated in Boston, New Bedford, Needham and Waltham, with sites in 8 other cities. 24 of the 52 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who obesity trials usually look for

Nearly every study sets a body mass index (BMI) threshold, most often 30 or higher, or 27 or higher when you also have a weight-related condition. Many ask that your weight has been stable for the last three months and that you are not currently using a prescription weight-loss drug. Age limits of 18 to 75 are common. Pregnancy, a history of pancreatitis or certain thyroid cancers, and bariatric surgery within the last few years are the exclusions that come up most.

If you have type 2 diabetes, look for trials that name it: some obesity studies exclude diabetes, while others are designed specifically for people who have both.

What taking part involves

A screening visit with a physical exam, blood work and an ECG usually comes first. Drug trials then run for six months to two years, with study visits every few weeks at the start and every one to three months later on. Most GLP-1 studies use a once-weekly injection you give yourself at home; many are placebo-controlled, meaning some participants receive an inactive version for part or all of the study, and you are told that before you agree to join. Study medication, visits and tests are provided at no cost, and most trials pay a stipend for time and travel.

Questions worth asking the study team

Whether there is a placebo group and how long it lasts; whether you can continue the medicine after the study ends; how many visits are required and how far the site is from you; and what happens if you need to stop early. Sites answer these every day and a ten-minute phone screen is the normal next step.

Showing 20 of 52 recruiting Obesity trials in Massachusetts

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3 Birmingham, Alabama +4 sites NCT07654374
This trial is looking for adults with obesity or overweight who also have type 2 diabetes. Participants will take either the drug aleniglipron or a placebo for 76 weeks to assess its effects.
Recruiting
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
PHASE3 Tucson, Arizona +4 sites NCT07817875
This trial is looking for children aged 6 to less than 12 years who have obesity. Participants will try a new treatment along with healthy lifestyle changes for about two years.
Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
PHASE3 Tucson, Arizona +4 sites NCT06672549
This trial is looking for teens aged 12 to under 18 who are struggling with obesity or being overweight. Participants must have tried losing weight before but were unsuccessful.
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3 Tuscaloosa, Alabama +4 sites NCT07321886
This trial is looking for adults who are overweight or have obesity but do not have type 2 diabetes. Participants will take eloralintide for a main phase lasting about 75 weeks, with an option to continue for another 2 years if they have prediabetes.
Recruiting
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
PHASE3 Birmingham, Alabama +4 sites NCT07654361
This trial is looking for adults with obesity or overweight who have health problems related to their weight. Participants will take a daily medication called aleniglipron for at least 76 weeks while following a reduced-calorie diet and increasing physical activity.
Recruiting
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
PHASE3 Phoenix, Arizona +4 sites NCT07481630
This trial is looking for adults with knee osteoarthritis and extra body weight. Participants will receive either an injection of NNC0487-0111 or a placebo once a week to see how it helps with weight loss and pain reduction.
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
PHASE2 Chandler, Arizona +4 sites NCT06143956
This trial is looking for adults who are overweight or have obesity to test different weight management treatments. Participants will be evaluated to see if they can safely join the trial.
Recruiting
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
PHASE2 Boston, Massachusetts NCT05933499
This trial is looking for adults with obesity who want to lose weight while keeping muscle and bone healthy. Participants will receive treatments for 52 weeks along with a weight loss lifestyle plan.
Recruiting
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA Boston, Massachusetts +1 sites NCT06138821
This trial is looking for adults with obesity and liver disease. Participants will either receive a procedure to help with weight loss or follow a diet alone.
Recruiting
PPDTM CorEvitasTM Obesity (OBR) Drug Effectiveness and Safety Registry
N/A Waltham, Massachusetts NCT07598981
This trial is looking for adults with obesity who are under a doctor’s care. Participants will share information about their health and treatments for obesity and may be prescribed medication for the first time.
Recruiting
Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.
N/A Boston, Massachusetts +1 sites NCT01998750
This trial is looking for children and adults with severe obesity that began before they turned 6 years old. Participants will answer questions about their health and eating habits, have a physical exam, and provide a saliva or blood sample for genetic testing.
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3 Anniston, Alabama +4 sites NCT07351045
This trial is looking for adults who are overweight or have obesity without type 2 diabetes. Participants will take a study drug or a placebo to help with weight management and will need to self-administer the treatment.
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
PHASE3 Fairhope, Alabama +4 sites NCT07784270
This trial is looking for adults with type 2 diabetes and obesity or being overweight. Participants will take AZD6234 or a placebo for 68 weeks to see how it affects their body weight.
Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3 Cullman, Alabama +4 sites NCT07284901
This trial is looking for people with obesity or overweight who also have type 2 diabetes. Participants will receive a weekly injection of ribupatide to see how it affects their weight and blood sugar levels.
Recruiting
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
PHASE3 Boston, Massachusetts +4 sites NCT06760546
This trial is looking for patients aged 4 and older with congenital hypothalamic obesity. Participants will take a daily injection of Setmelanotide or a placebo for up to 26 weeks to assess its effects on weight, hunger, and quality of life.
Recruiting
Oxytocin for Weight Loss in Adolescents
PHASE2 Boston, Massachusetts NCT04551482
This trial is looking for teenagers aged 10 to 18 who are struggling with obesity. Participants will receive either oxytocin or a placebo nasal spray, taken four times a day for 12 weeks, while attending regular study visits and assessments.
Recruiting
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
PHASE1 Boston, Massachusetts +4 sites NCT06239116
This trial is looking for healthy adults and patients aged 12 to 65 with obesity related to hypothalamic injury or Prader-Willi Syndrome. Participants will take RM-718 and help researchers find out how safe the drug is and how it works in the body.
Recruiting
Postnatal Exercise to Activate Baby's Brown Fat
NA Boston, Massachusetts +1 sites NCT07467694
This trial is looking for women aged 18 to 45 who are pregnant or recently gave birth. Participants will engage in exercise to see how it affects their breastmilk and their baby's health.
Recruiting
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
N/A Boston, Massachusetts +2 sites NCT07776678
This trial is looking for healthy adults aged 18 and older to help evaluate different ways to measure body fat and weight. Participants will undergo various assessments, including body scans and blood tests, and will need to follow specific guidelines before their visits.
Recruiting
Trans-nasal Endoscopy for Bariatric Patients
NA Boston, Massachusetts NCT06200961
This trial is looking for adults aged 18 to 90 who have gastrointestinal issues and are being treated at a metabolic and bariatric clinic. Participants will undergo a new type of endoscopy to evaluate their condition.
Recruiting

Where the Obesity studies are in Massachusetts

  • Brigham and Women's Hospital, Boston8 trials
  • Massachusetts General Hospital, Boston8 trials
  • Lucida Clinical Trials, New Bedford5 trials
  • Boston Children's Hospital, Boston4 trials
  • Knownwell, Needham3 trials
  • Brigham and Women's Hospital Diabetes Program, Boston2 trials

Counts are recruiting studies listing at least one site in Massachusetts, from ClinicalTrials.gov, refreshed every two days.

Obesity clinical trials in Massachusetts: common questions

How many Obesity clinical trials are recruiting in Massachusetts?
TrialFinder currently lists 52 recruiting Obesity clinical trials with study sites in Massachusetts. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Obesity clinical trials located in Massachusetts?
Study sites for the Obesity trials listed on this page include Boston, Waltham. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Obesity clinical trial in Massachusetts?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Obesity trials in Massachusetts also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Obesity clinical trial in Massachusetts?
Each study sets its own criteria based on age, Obesity diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need a BMI over 30 to join an obesity clinical trial?
Most adult obesity trials require a BMI of 30 or higher, or 27 or higher if you also have a weight-related condition such as high blood pressure, prediabetes or sleep apnea. Each trial page lists its exact threshold.
Are obesity trial participants paid?
Study medication, visits and tests are provided free, and most obesity trials pay a stipend per visit for time and travel. The amount is set by each study and told to you before you enroll; it is never contingent on finishing the study.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Obesity trials near you in Massachusetts.

Get Matched — Free
No insurance required

Obesity trials study GLP-1 receptor agonists, bariatric procedures, behavioural interventions, and combination weight-loss therapies in adults and adolescents.

All Obesity trials →